- Home
- DOUG vs TVGN Comparison
DOUG vs TVGN Comparison
Compare DOUG & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- TVGN
- Stock Information
- Founded
- DOUG 1911
- TVGN 2020
- Country
- DOUG United States
- TVGN United States
- Employees
- DOUG N/A
- TVGN N/A
- Industry
- DOUG Building operators
- TVGN Blank Checks
- Sector
- DOUG Real Estate
- TVGN Finance
- Exchange
- DOUG Nasdaq
- TVGN Nasdaq
- Market Cap
- DOUG 161.5M
- TVGN 193.1M
- IPO Year
- DOUG N/A
- TVGN N/A
- Fundamental
- Price
- DOUG $3.03
- TVGN $1.06
- Analyst Decision
- DOUG
- TVGN Strong Buy
- Analyst Count
- DOUG 0
- TVGN 1
- Target Price
- DOUG N/A
- TVGN $10.00
- AVG Volume (30 Days)
- DOUG 1.0M
- TVGN 645.6K
- Earning Date
- DOUG 08-01-2025
- TVGN 08-13-2025
- Dividend Yield
- DOUG N/A
- TVGN N/A
- EPS Growth
- DOUG N/A
- TVGN N/A
- EPS
- DOUG N/A
- TVGN N/A
- Revenue
- DOUG $1,048,791,000.00
- TVGN N/A
- Revenue This Year
- DOUG $17.61
- TVGN N/A
- Revenue Next Year
- DOUG N/A
- TVGN N/A
- P/E Ratio
- DOUG N/A
- TVGN N/A
- Revenue Growth
- DOUG 11.36
- TVGN N/A
- 52 Week Low
- DOUG $1.28
- TVGN $0.26
- 52 Week High
- DOUG $3.20
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- DOUG 74.53
- TVGN 36.03
- Support Level
- DOUG $2.70
- TVGN $1.18
- Resistance Level
- DOUG $2.82
- TVGN $1.42
- Average True Range (ATR)
- DOUG 0.12
- TVGN 0.07
- MACD
- DOUG 0.05
- TVGN -0.02
- Stochastic Oscillator
- DOUG 99.25
- TVGN 5.26
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.